BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Emerging Biotech

Metabolon Secures $25 Million of Funding to Accelerate Growth

The proceeds will be used for general corporate purposes, helping Metabolon further accelerate commercialization activities and continue advancing its well...

January 25, 2023 | News

AstraZeneca Begins Tender Offer to Acquire CinCor Pharma, Inc.

On 9 January 2023, AstraZeneca announced that it had entered into a definitive agreement to acquire CinCor. Following the successful closing of the tender ...

January 23, 2023 | News

KBI Biopharma Announces Subcontract with Mapp Biopharmaceutical on Sudan ebolavirus Treatment

KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, today announced it entered into a subcontract with Mapp Biopharmaceutical, Inc. (Mapp) for the cont...

January 23, 2023 | News

Pioneering research from UAE students driving the future of the region’s healthcare industry

Arab Health to support the next generation of healthcare specialists in the region with the launch of the Future Doctor Programme for undergradua...

January 23, 2023 | News

German pharma company selects Generis’ CARA Life Sciences Platform to unify their clinical processes

Cheplapharm were looking for a solution to enable them to move away from manual data processes and using multiple separate systems including Excel, which l...

January 19, 2023 | News

FAPON presents at 41st Annual J.P. Morgan Healthcare Conference

FAPON focuses on three business lines: raw materials and solutions, the IVD ecosystem, and intelligent digital diagnosis & treatment. Supported by its ...

January 17, 2023 | News

Juniper Biologics Partners With Caris Life Sciences® for Molecular Profiling Distribution in South East Asia

The company's suite of market-leading molecular profiling offerings assess DNA, RNA and proteins to reveal a molecular blueprint that helps patients, physi...

January 12, 2023 | News

BioVersys Extends its Series C Round to CHF 32.6 Million with Investment from the AMR Action Fund

BioVersys AG, a privately held clinical stage, multi-asset Swiss pharmaceutical company focusing on research and development of therapies for life-th...

January 06, 2023 | News

Duality Biologics Announces License Agreement of its Next-generation ADC platform with Adcendo

Duality to grant license of DITAC (Duality Immune Toxin Antibody Conjugates) platform to Adcendo for its lead uPARAP ADC program Duality to receive upfr...

January 05, 2023 | News

Legend Biotech Announces Acceptance of Its New Drug Application for Ciltacabtagene Autoleucel (Cilta-Cel) in China

This submission is based on data from the confirmatory Phase 2 clinical study CARTIFAN-1 (NCT03758417) conducted in China, which evaluated the efficacy and...

January 03, 2023 | News

JelloX Biotech Leads Research in 3D Cancer Pathology as NCI Explores Potential

Presently, most cancer diagnosis is done through thinly sliced physical biopsies. Though widespread, the amount of information this method collects remains...

December 06, 2022 | News

Inventia enters into a distribution agreement for RASTRUM™ with SCRUM Inc in Japan

RASTRUM™, is a game-changing 3D cell culture platform that’s accelerating the quest to cure cancer and debilitating diseases. With applications...

December 05, 2022 | News

Scipio bioscience announces single-cell Grant Program for four researchers valued up to US$30,000

With the debut of its novel single-cell solution and its first Grant Program, Scipio bioscience is creating an era where scRNA-seq is versatile, flexible, ...

December 02, 2022 | News

Rocket Pharmaceuticals Completes Acquisition of Renovacor

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a leading late-stage biotechnology company advancing an integrated and sustainable pipeline of genetic th...

December 02, 2022 | News

Stay Connected